货号: CL-0116
Price: ¥1400 ¥1400
生长培养基: DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | HSC-T6(大鼠肝星形细胞) |
别称 | HSCT6 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:DMEM[PM150210]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
年龄(性别) | Adult Female |
组织来源 | 未知 |
细胞类型 | 转化细胞系 |
STR位点信息
STR鉴定图
-
Targeted delivery of polymeric NO-donor micelles to hepatic stellate cells for restoration of liver function and inhibition of hepatic fibrosis(2025)
作者:Rui Yang, Lifen Yang, Ni Zhang, Yuqing Wan, Shineng Chen, Yiqing Xiao, Xiaoping Liang, Shangjie Yang, Yinan Zhong, Dechun Huang, Wei Chen, Bingbing Zhao
期刊:JOURNAL OF CONTROLLED RELEASE
DOI:10.1016/j.jconrel.2025.01.036
影响因子:10.5
-
Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells(2025)
作者:Yujing Tao, Qun Niu, Yuanqian Yao, Kaixin Wang, Haijian Dong, Xin Zhao, Zijian Zeng, Hui Li
期刊:Frontiers in Pharmacology
DOI:10.3389/fphar.2024.1528100
影响因子:4.4
引用产品: HSC-T6 细胞
-
Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance(2025)
作者:Wenjing Xue, Haiqing Liu, Ziheng Su, Siqi Wang, Junping Cheng, Yunzhi Pan, Lurong Zhang
期刊:Frontiers in Pharmacology
DOI:10.3389/fphar.2025.1525914
影响因子:4.4
引用产品: HSC-T6 细胞
-
MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells(2024)
作者:Deng Yalan, Lu Liqing, Zhu Dandan, Zhang Huajun, Fu Ying, Tan Yuying, Tan Xuemei, Guo Ming, Zhang Ye, Yang Heping, Yang Bing, Liu Ting, Chen Yongheng
期刊:CELL DEATH AND DIFFERENTIATION
DOI:10.1038/s41418-024-01322-5
影响因子:13.7
-
Dual-Integrin-Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy(2024)
作者:Bowen Li, Jianwei Bao, Yan Huang, Jikang Liu, Xuehai Yan, Qianli Zou
期刊:Small
影响因子:13.0
引用产品: HSC-T6 细胞
-
Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis(2024)
作者:Lei Wang, Jieying Zhou, Jian Wang, Xiaotang Wang, Haijuan Dong, Lingzhi Zhao, Junchen Wu, Juanjuan Peng
期刊:Advanced Healthcare Materials
影响因子:10.0
-
Oxytocin alleviates liver fibrosis via hepatic macrophages(2024)
作者:Xiangyu Zhai, Hao Zhang, Zhijia Xia, Mingkun Liu, Gang Du, Zhengchen Jiang, Huaxin Zhou, Dan Luo, Dandan Dou, Jingxin Li, Wei Wang, Xiaosong Li, Bin Jin
期刊:JHEP Reports
DOI:10.1016/j.jhepr.2024.101032
影响因子:8.3
引用产品: HSC-T6 细胞, RAW 264.7 细胞, NCTC clone 929 [L 细胞, L-929] 细胞, THP-1 细胞
-
Target-Engineered Liposomes Decorated with Nanozymes Alleviate Liver Fibrosis by Remodeling the Liver Microenvironment(2024)
作者:Dejun Yang, Kai Liu, Chunyan Cai, Jingjing Xi, Chunmei Yan, Zhaolei Peng, Yulin Wang, Lin Jing, Ying Zhang, Fan Xie, Xiaofang Li
期刊:ACS Applied Materials & Interfaces
影响因子:8.3
引用产品: RAW 264.7 细胞, HSC-T6 细胞, AML12 细胞
-
Preparation of pectin-coated and chitosan-coated phenylethanoside liposomes: Studies on characterization, stability, digestion and release behavior(2024)
作者:Lingling Su, Dandan Zhao, Qiong Huang, Xia Zhao, Qijia Chen, Huan Rao, Limin Guo, Jianxiong Hao
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2024.129442
影响因子:8.2
引用产品: HSC-T6 细胞, NR8383 [AgC11x3A; NR8383.1] 细胞, HSC-T6细胞专用培养基, NR8383细胞专用培养基
-
BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells(2024)
作者:Dan Zhu, Zongbin Sun, Jiayun Wei, Yulin Zhang, Wenjing An, Yan Lin, Xun Li
期刊:International Journal of Nanomedicine
影响因子:8.0
引用产品: HSC-T6 细胞, LX-2 细胞, 293T [HEK-293T] 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图